Successful immunotherapy in life-threatening parvovirus B19 infection in a child

Pediatric Infectious Disease Journal

Volumn 32, Issue 7, 2013, Pages 789-792

  Butin, Marine ^a   Mekki, Yahia ^b   Phan, Alice ^a   Billaud, Geneviève ^b   Di Filippo, Sylvie ^c   Javouhey, Etienne ^d   Cochat, Pierre ^a   Belot, Alexandre ^a  

^a HFME   (France)

^b Hospices Civils de Lyon   (France)

^c LOUIS PRADEL HOSPITAL   (France)

^d HOSPICES CIVILS DE LYON   (France)

Author keywords

Anakinra; Macrophage activation syndrome; Myocarditis; Parvovirus B19; Still disease

Indexed keywords

CYCLOSPORIN; IMMUNOGLOBULIN; INTERLEUKIN 1 ANTIBODY; METHYLPREDNISOLONE; PREDNISONE; RECOMBINANT INTERLEUKIN 1 RECEPTOR BLOCKING AGENT;

ARTICLE; AUTOINFLAMMATORY DISEASE; BLOOD CULTURE; CASE REPORT; CELL PROLIFERATION; CHILD; CHILDHOOD DISEASE; CYTOLYSIS; ECHOCARDIOGRAPHY; ERYTHEMA INFECTIOSUM; FEVER; HEART DILATATION; HEART INJURY; HEART SURGERY; HEART TAMPONADE; HUMAN; HYPERFERRITINEMIA; HYPERTRIGLYCERIDEMIA; HYPOFIBRINOGENEMIA; IMMUNOCOMPROMISED PATIENT; IMMUNOTHERAPY; JUVENILE RHEUMATOID ARTHRITIS; LEFT VENTRICULAR SYSTOLIC DYSFUNCTION; LIMB PAIN; MACROPHAGE ACTIVATION SYNDROME; MALE; MYCOPLASMA PNEUMONIAE; MYOCARDITIS; PERICARDIAL BIOPSY; PERICARDIAL EFFUSION; POLYMERASE CHAIN REACTION; PRESCHOOL CHILD; PRIORITY JOURNAL; RASH; SEROCONVERSION; THROMBOCYTOPENIA; VIRUS LOAD;

AUTOIMMUNE DISEASES; CHILD; HUMANS; IMMUNOLOGIC FACTORS; IMMUNOTHERAPY; MALE; PARVOVIRIDAE INFECTIONS; PARVOVIRUS B19, HUMAN; TREATMENT OUTCOME;

EID: 84883248433     PISSN: 08913668     EISSN: 15320987     Source Type: Journal    
DOI: 10.1097/INF.0b013e31828df4d1     Document Type: Article

References (25)

1. Heegaard ED, Brown KE. Human parvovirus B19. Clin Microbiol Rev. 2002;15:485-505.
2. Heegaard ED, Hornsleth A. Parvovirus: the expanding spectrum of disease. Acta Paediatr. 1995;84:109-117.
3. de Jong EP, Walther FJ, Kroes AC, et al. Parvovirus B19 infection in pregnancy: new insights and management. Prenat Diagn. 2011;31:419-425.
4. Florea AV, Ionescu DN, Melhem MF. Parvovirus B19 infection in the immunocompromised host. Arch Pathol Lab Med. 2007;131:799-804.
5. Brodin-Sartorius A, Mekki Y, Bloquel B, et al. Parvovirus B19 infection after kidney transplantation. Nephrol Ther. 2012;8:5-12.
6. Dina J, Vabret A, Rambaud C, et al. Fulminant myocarditis associated with parvovirus B19 infection in a child. J Clin Virol. 2008;42:70-71.
7. Dina J, Villedieu F, Labombarda F, et al. Childhood myocarditis and parvovirus B19 genotypes. J Clin Virol. 2011;50:61-64.
8. Koehl B, Oualha M, Lesage F, et al. Fatal parvovirus B19 myocarditis in children and possible dysimmune mechanism. Pediatr Infect Dis J. 2012;31:418-421.
9. Murry CE, Jerome KR, Reichenbach DD. Fatal parvovirus myocarditis in a 5-year-old girl. Hum Pathol. 2001;32:342-345.
10. Papadogiannakis N, Tolfvenstam T, Fischler B, et al. Active, fulminant, lethal myocarditis associated with parvovirus B19 infection in an infant. Clin Infect Dis. 2002;35:1027-1031.
11. Zack F, Klingel K, Kandolf R, et al. Sudden cardiac death in a 5-year-old girl associated with parvovirus B19 infection. Forensic Sci Int. 2005;155:13-17.
12. Kaya Z, Oztürk G, Gürsel T, et al. Spontaneous resolution of hemophagocytic syndrome and disseminated intravascular coagulation associated with parvovirus b19 infection in a previously healthy child. Jpn J Infect Dis. 2005;58:149-151.
13. Larroche C, Scieux C, Honderlick P, et al. Spontaneous resolution of hemophagocytic syndrome associated with acute parvovirus B19 infection and concomitant Epstein-Barr virus reactivation in an otherwise healthy adult. Eur J Clin Microbiol Infect Dis. 2002;21:739-742.
14. Molina KM, Garcia X, Denfield SW, et al. Parvovirus B19 myocarditis causes significant morbidity and mortality in children. Pediatr Cardiol. 2013;34:390-397.
15. Sairam S, Goel N, Lisse J, et al. Pericardial effusion and cardiomyopathy following arthritis with parvovirus B19 infection: response to intravenous immunoglobulin. J Clin Rheumatol. 2001;7:346-349.
16. Oguz F, Akdeniz C, Unüvar E, et al. Parvovirus B19 in the acute arthropathies and juvenile rheumatoid arthritis. J Paediatr Child Health. 2002;38:358-362.
17. Takahashi Y, Murai C, Shibata S, et al. Human parvovirus B19 as a causative agent for rheumatoid arthritis. Proc Natl Acad Sci USA. 1998;95:8227-8232.
18. Lehmann HW, Plentz A, von Landenberg P, et al. Different patterns of disease manifestations of parvovirus B19-associated reactive juvenile arthritis and the induction of antiphospholipid-antibodies. Clin Rheumatol. 2008;27:333-338.
19. Sève P, Ferry T, Koenig M, et al. Lupus-like presentation of parvovirus B19 infection. Semin Arthritis Rheum. 2005;34:642-648.
20. Ramos-Casals M, Cuadrado MJ, Alba P, et al. Acute viral infections in patients with systemic lupus erythematosus: description of 23 cases and review of the literature. Medicine (Baltimore). 2008;87:311-318.
21. von Landenberg P, Lehmann HW, Modrow S. Human parvovirus B19 infection and antiphospholipid antibodies. Autoimmun Rev. 2007;6:278-285.
22. Lehmann HW, von Landenberg P, Modrow S. Parvovirus B19 infection and autoimmune disease. Autoimmun Rev. 2003;2:218-223.
23. Lunardi C, Tinazzi E, Bason C, et al. Human parvovirus B19 infection and autoimmunity. Autoimmun Rev. 2008;8:116-120.
24. Woo P. Anakinra treatment for systemic juvenile idiopathic arthritis and adult onset Still disease. Ann Rheum Dis. 2008;67:281-282.
25. Tzang BS, Chiu CC, Tsai CC, et al. Effects of human parvovirus B19 VP1 unique region protein on macrophage responses. J Biomed Sci. 2009;16:13.